Filtros de búsqueda

Lista de obras de Rémi Letestu

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

artículo científico publicado en 2015

Bone marrow aspiration for diagnostic purposes

artículo científico publicado en 2003

Deciphering leukemic B-cell chronic lymphoproliferative disorders.

artículo científico publicado en 2006

Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates

artículo científico publicado en 2001

Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.

artículo científico publicado en 2009

Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia

artículo científico publicado en 2015

Evaluation of Fluorescently Labeled Aerolysin as a New Kind of Reagent for Flow Cytometry Tests: Optimization of Use of FLAER, Hints, and Limits

scientific article published on 27 February 2016

Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process

artículo científico publicado en 2006

Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis

artículo científico publicado en 2007

Evaluation of paroxysmal nocturnal hemoglobinuria screening by flow cytometry through multicentric interlaboratory comparison in four countries.

artículo científico publicado en 2015

Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.

artículo científico publicado en 2012

Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia

artículo científico publicado en 2005

Flow cytometry APC-tandem dyes are degraded through a cell-dependent mechanism.

artículo científico publicado en 2009

HBME-1 is expressed by erythroid precursors in early maturation stage and can be a valuable tool for evaluation of dyserythropoiesis in bone marrow core biopsy specimens

artículo científico publicado en 2016

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL.

artículo científico publicado en 2012

Induction of endoplasmic reticulum calcium pump expression during early leukemic B cell differentiation

artículo científico publicado en 2017

Intracellular trafficking of the alphaIIbbeta3 receptor antagonist, abciximab, in normal and Glanzmann's disease megakaryocytes

artículo científico publicado en 1999

National standardization of ZAP-70 determination by flow cytometry: The French experience

article

Old DAT and new data: positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients.

artículo científico publicado en 2014

Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand? ⬇️

artículo científico publicado el 19 de septiembre de 2011

Prognosis of Binet stage A chronic lymphocytic leukemia patients: the strength of routine parameters

artículo científico publicado en 2010

Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders.

artículo científico publicado en 2004

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

scientific article published on 15 September 2020

Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups.

artículo científico publicado en 2016

Rituximab for patients with refractory mucous membrane pemphigoid.

artículo científico publicado en 2011

Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100™.

artículo científico publicado en 2010

Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression.

artículo científico publicado en 2006

Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancy

artículo científico publicado en 2007

TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypes

artículo científico publicado en 2016

The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia.

artículo científico publicado en 2012

Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiation

artículo científico publicado en 2000

Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring

artículo científico publicado en 2007

[Cold agglutinin!...].

scientific article published on 01 July 2005

miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda